Review





Similar Products

94
Tocris small molecule inhibitor rpcamps
Small Molecule Inhibitor Rpcamps, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpcamps/cAMPS-Rp%2C+triethylammonium+salt/pmc10153428-277-0-6
Average 94 stars, based on 1 article reviews
small molecule inhibitor rpcamps - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Tocris rpcamp tocris
Rpcamp Tocris, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpcamps/cAMPS-Rp%2C+triethylammonium+salt/pmc09722584__res___131___1018___s006-1-192-193
Average 93 stars, based on 1 article reviews
rpcamp tocris - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Tocris rpcamp
Rpcamp, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpcamps/rpcamp/pmc09722584__res___131___1018___s006-0-140-141
Average 90 stars, based on 1 article reviews
rpcamp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Millipore rpcamp (cat. # 151837–09-1)
Rpcamp (Cat. # 151837–09 1), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpcamps/rpcamp++cat++++151837+09+1+/pm36075465-56-6-18
Average 90 stars, based on 1 article reviews
rpcamp (cat. # 151837–09-1) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Millipore rpcamps
Rpcamps, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpcamps/rpcamps/pm34274479-42-13-14
Average 90 stars, based on 1 article reviews
rpcamps - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Tocris rpcamps 1337/1
Rpcamps 1337/1, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpcamps/rpcamps+1337+1/pm32220335-212-8-13
Average 90 stars, based on 1 article reviews
rpcamps 1337/1 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Tocris rpcamps
Rpcamps, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpcamps/cAMPS-Rp%2C+triethylammonium+salt/pm32220335-212-11-13
Average 93 stars, based on 1 article reviews
rpcamps - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
Dostmann Electronic cell-permeable pka inhibitor rpcamp
<t>PKA</t> inhibition with <t>RPcAMP</t> or H89 largely restores the suppressed KCa-sAHP and IsAHP in chronic-phase post-SE neurons. Aa, b, Representative recordings of a KCa-sAHP evoked by a Ca2+ spike (shown in inset; a) and an IsAHP evoked by a depolarizing pulse (b) in a non-SE neuron. B, Same as in A, but recordings were made in a post-SE neuron. C, Same as in A, but recordings were made in non-SE slices treated for >1 h with the PKA inhibitor RPcAMP (100 μm). D, Same as in B, but recordings were made in post-SE slices treated for >1 h with the PKA inhibitor RPcAMP. E, Same as in C, but recordings were made in non-SE slices treated for >1 h with the PKA inhibitor H89 (10 μm). F, Same as in D, but recordings were made in post-SE slices treated for >1 h with the PKA inhibitor H89. Note that in this condition the KCa-sAHP and IsAHP in the non-SE and post-SE neurons appear similar in size. G, Summary bar diagram of KCa-sAHP amplitudes (measured at the peak of the sAHP) in non-SE and post-SE neurons recorded in normal aCSF and in RPcAMP or H89-containing aCSF. H, Summary bar diagram of IsAHP amplitudes (measured at peak current) in non-SE and post-SE neurons recorded in normal aCSF and RPcAMP or H89 containing aCSF. Note that both KCa-sAHP and IsAHP values are markedly and significantly reduced in post-SE neurons, and are largely restored by treating slices with PKA inhibitors (RPcAMP or H89). I, Spikes were evoked by a series of 1-s-long depolarizing current pulses in non-SE and post-SE neurons, all treated with H89. The two plots depict the number of spikes versus stimulus intensity in the two groups of neurons. Although post-SE neurons fire more spikes, the difference between the two plots is not significant, indicating that H89 treatment reduces the excitability of post-SE neurons to near the non-SE level. ***p ≤ 0.001. n.s., Not significant.
Cell Permeable Pka Inhibitor Rpcamp, supplied by Dostmann Electronic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpcamps/inhibitor+rp+camps/pmc06978949-346-9-14
Average 90 stars, based on 1 article reviews
cell-permeable pka inhibitor rpcamp - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Millipore rp-adenosine 3′,5′-cyclic monophosphorothioate (rpcamps
<t>PKA</t> inhibition with <t>RPcAMP</t> or H89 largely restores the suppressed KCa-sAHP and IsAHP in chronic-phase post-SE neurons. Aa, b, Representative recordings of a KCa-sAHP evoked by a Ca2+ spike (shown in inset; a) and an IsAHP evoked by a depolarizing pulse (b) in a non-SE neuron. B, Same as in A, but recordings were made in a post-SE neuron. C, Same as in A, but recordings were made in non-SE slices treated for >1 h with the PKA inhibitor RPcAMP (100 μm). D, Same as in B, but recordings were made in post-SE slices treated for >1 h with the PKA inhibitor RPcAMP. E, Same as in C, but recordings were made in non-SE slices treated for >1 h with the PKA inhibitor H89 (10 μm). F, Same as in D, but recordings were made in post-SE slices treated for >1 h with the PKA inhibitor H89. Note that in this condition the KCa-sAHP and IsAHP in the non-SE and post-SE neurons appear similar in size. G, Summary bar diagram of KCa-sAHP amplitudes (measured at the peak of the sAHP) in non-SE and post-SE neurons recorded in normal aCSF and in RPcAMP or H89-containing aCSF. H, Summary bar diagram of IsAHP amplitudes (measured at peak current) in non-SE and post-SE neurons recorded in normal aCSF and RPcAMP or H89 containing aCSF. Note that both KCa-sAHP and IsAHP values are markedly and significantly reduced in post-SE neurons, and are largely restored by treating slices with PKA inhibitors (RPcAMP or H89). I, Spikes were evoked by a series of 1-s-long depolarizing current pulses in non-SE and post-SE neurons, all treated with H89. The two plots depict the number of spikes versus stimulus intensity in the two groups of neurons. Although post-SE neurons fire more spikes, the difference between the two plots is not significant, indicating that H89 treatment reduces the excitability of post-SE neurons to near the non-SE level. ***p ≤ 0.001. n.s., Not significant.
Rp Adenosine 3′,5′ Cyclic Monophosphorothioate (Rpcamps, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rpcamps/adenosine+3+5++cyclic+monophosphorothioate++rp+isomer/pmc05997511-259-20-26
Average 90 stars, based on 1 article reviews
rp-adenosine 3′,5′-cyclic monophosphorothioate (rpcamps - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


PKA inhibition with RPcAMP or H89 largely restores the suppressed KCa-sAHP and IsAHP in chronic-phase post-SE neurons. Aa, b, Representative recordings of a KCa-sAHP evoked by a Ca2+ spike (shown in inset; a) and an IsAHP evoked by a depolarizing pulse (b) in a non-SE neuron. B, Same as in A, but recordings were made in a post-SE neuron. C, Same as in A, but recordings were made in non-SE slices treated for >1 h with the PKA inhibitor RPcAMP (100 μm). D, Same as in B, but recordings were made in post-SE slices treated for >1 h with the PKA inhibitor RPcAMP. E, Same as in C, but recordings were made in non-SE slices treated for >1 h with the PKA inhibitor H89 (10 μm). F, Same as in D, but recordings were made in post-SE slices treated for >1 h with the PKA inhibitor H89. Note that in this condition the KCa-sAHP and IsAHP in the non-SE and post-SE neurons appear similar in size. G, Summary bar diagram of KCa-sAHP amplitudes (measured at the peak of the sAHP) in non-SE and post-SE neurons recorded in normal aCSF and in RPcAMP or H89-containing aCSF. H, Summary bar diagram of IsAHP amplitudes (measured at peak current) in non-SE and post-SE neurons recorded in normal aCSF and RPcAMP or H89 containing aCSF. Note that both KCa-sAHP and IsAHP values are markedly and significantly reduced in post-SE neurons, and are largely restored by treating slices with PKA inhibitors (RPcAMP or H89). I, Spikes were evoked by a series of 1-s-long depolarizing current pulses in non-SE and post-SE neurons, all treated with H89. The two plots depict the number of spikes versus stimulus intensity in the two groups of neurons. Although post-SE neurons fire more spikes, the difference between the two plots is not significant, indicating that H89 treatment reduces the excitability of post-SE neurons to near the non-SE level. ***p ≤ 0.001. n.s., Not significant.

Journal: The Journal of Neuroscience

Article Title: Protein Kinase A-Mediated Suppression of the Slow Afterhyperpolarizing KCa3.1 Current in Temporal Lobe Epilepsy

doi: 10.1523/JNEUROSCI.1603-19.2019

Figure Lengend Snippet: PKA inhibition with RPcAMP or H89 largely restores the suppressed KCa-sAHP and IsAHP in chronic-phase post-SE neurons. Aa, b, Representative recordings of a KCa-sAHP evoked by a Ca2+ spike (shown in inset; a) and an IsAHP evoked by a depolarizing pulse (b) in a non-SE neuron. B, Same as in A, but recordings were made in a post-SE neuron. C, Same as in A, but recordings were made in non-SE slices treated for >1 h with the PKA inhibitor RPcAMP (100 μm). D, Same as in B, but recordings were made in post-SE slices treated for >1 h with the PKA inhibitor RPcAMP. E, Same as in C, but recordings were made in non-SE slices treated for >1 h with the PKA inhibitor H89 (10 μm). F, Same as in D, but recordings were made in post-SE slices treated for >1 h with the PKA inhibitor H89. Note that in this condition the KCa-sAHP and IsAHP in the non-SE and post-SE neurons appear similar in size. G, Summary bar diagram of KCa-sAHP amplitudes (measured at the peak of the sAHP) in non-SE and post-SE neurons recorded in normal aCSF and in RPcAMP or H89-containing aCSF. H, Summary bar diagram of IsAHP amplitudes (measured at peak current) in non-SE and post-SE neurons recorded in normal aCSF and RPcAMP or H89 containing aCSF. Note that both KCa-sAHP and IsAHP values are markedly and significantly reduced in post-SE neurons, and are largely restored by treating slices with PKA inhibitors (RPcAMP or H89). I, Spikes were evoked by a series of 1-s-long depolarizing current pulses in non-SE and post-SE neurons, all treated with H89. The two plots depict the number of spikes versus stimulus intensity in the two groups of neurons. Although post-SE neurons fire more spikes, the difference between the two plots is not significant, indicating that H89 treatment reduces the excitability of post-SE neurons to near the non-SE level. ***p ≤ 0.001. n.s., Not significant.

Article Snippet: To that end, we treated chronic-phase slices with the cell-permeable PKA inhibitor RPcAMP ( Dostmann et al., 1990 ; Wang et al., 1991 ).

Techniques: Inhibition